meptazinol has been researched along with Age-Related Memory Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Li, J; Ni, W; Qiu, Y; Tan, X; Yang, Y; Zhao, F; Zhao, L; Zheng, W; Zhou, Y | 1 |
| Chen, HZ; Cui, Y; Ge, XX; Li, J; Liu, T; Qiu, ZB; Wang, H; Xia, Z; Xie, Q; Xu, J; Xu, JR; Zhang, WW | 1 |
2 other study(ies) available for meptazinol and Age-Related Memory Disorders
| Article | Year |
|---|---|
A Multifunctional (-)-Meptazinol-Serotonin Hybrid Ameliorates Oxidative Stress-Associated Apoptotic Neuronal Death and Memory Deficits via Activating the Nrf2/Antioxidant Enzyme Pathway.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Apoptosis; Glutathione; Heme Oxygenase-1; Humans; Hydrogen Peroxide; Kelch-Like ECH-Associated Protein 1; Memory Disorders; Meptazinol; Mice; Molecular Docking Simulation; Neuroblastoma; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Scopolamine Derivatives; Serotonin | 2023 |
Bis(9)-(-)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Brain; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Female; Humans; Kinetics; Male; Maze Learning; Memory Disorders; Meptazinol; Mice; Models, Molecular; Nootropic Agents; Scopolamine; Sesquiterpenes | 2013 |